Jane E Salmon1, Chieko Mineo2, Victoria Ulrich2, Shari E Gelber3, Milena Vukelic1, Anastasia Sacharidou2, Joachim Herz4, Rolf T Urbanus5, Philip G de Groot5, David R Natale6, Anirudha Harihara6, Patricia Redecha1, Vikki M Abrahams7, Philip W Shaul2. 1. Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York. 2. Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. 3. Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York. 4. Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas. 5. Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands. 6. Department of Reproductive Medicine, University of California-San Diego, San Diego, California. 7. Department of Obstetrics, Gynecology & Reproductive Sciences, Divisions of Reproductive Sciences and Maternal-Fetal Medicine, Yale School of Medicine, New Haven, Connecticut.
Abstract
OBJECTIVE: Pregnancies in women with the antiphospholipid syndrome (APS) are frequently complicated by fetal loss and intrauterine growth restriction (IUGR). How circulating antiphospholipid antibodies (aPL) cause pregnancy complications in APS is poorly understood. We sought to determine whether the low-density lipoprotein receptor family member apolipoprotein E receptor 2 (ApoER2) mediates trophoblast dysfunction and pregnancy complications induced by aPL. METHODS: Placental and trophoblast ApoER2 expression was evaluated by immunohistochemistry and immunoblotting. Normal human IgG and aPL were purified from healthy individuals and APS patients, respectively. The role of ApoER2 in aPL-induced changes in trophoblast proliferation and migration and in kinase activation was assessed using RNA interference in HTR-8/SVneo cells. The participation of ApoER2 in aPL-induced pregnancy loss and IUGR was evaluated in pregnant ApoER2(+/+) and ApoER2(-/-) mice injected with aPL or normal human IgG. RESULTS: We found that ApoER2 is abundant in human and mouse placental trophoblasts and in multiple trophoblast-derived cell lines, including HTR-8/SVneo cells. ApoER2 and its interaction with the cell surface protein β2 -glycoprotein I were required for aPL-induced inhibition of cultured trophoblast proliferation and migration. In parallel, aPL antagonism of Akt kinase activation by epidermal growth factor in trophoblasts was mediated by ApoER2. Furthermore, in a murine passive-transfer model of pregnancy complications of APS, ApoER2(-/-) mice were protected from both aPL-induced fetal loss and aPL-induced IUGR. CONCLUSION: ApoER2 plays a major role in the attenuation of trophoblast function by aPL, and the receptor mediates aPL-induced pregnancy complications in vivo in mice. ApoER2-directed interventions can now potentially be developed to combat the pregnancy complications associated with APS.
OBJECTIVE: Pregnancies in women with the antiphospholipid syndrome (APS) are frequently complicated by fetal loss and intrauterine growth restriction (IUGR). How circulating antiphospholipid antibodies (aPL) cause pregnancy complications in APS is poorly understood. We sought to determine whether the low-density lipoprotein receptor family member apolipoprotein E receptor 2 (ApoER2) mediates trophoblast dysfunction and pregnancy complications induced by aPL. METHODS: Placental and trophoblast ApoER2 expression was evaluated by immunohistochemistry and immunoblotting. Normal human IgG and aPL were purified from healthy individuals and APSpatients, respectively. The role of ApoER2 in aPL-induced changes in trophoblast proliferation and migration and in kinase activation was assessed using RNA interference in HTR-8/SVneo cells. The participation of ApoER2 in aPL-induced pregnancy loss and IUGR was evaluated in pregnant ApoER2(+/+) and ApoER2(-/-) mice injected with aPL or normal human IgG. RESULTS: We found that ApoER2 is abundant in human and mouse placental trophoblasts and in multiple trophoblast-derived cell lines, including HTR-8/SVneo cells. ApoER2 and its interaction with the cell surface protein β2 -glycoprotein I were required for aPL-induced inhibition of cultured trophoblast proliferation and migration. In parallel, aPL antagonism of Akt kinase activation by epidermal growth factor in trophoblasts was mediated by ApoER2. Furthermore, in a murine passive-transfer model of pregnancy complications of APS, ApoER2(-/-) mice were protected from both aPL-induced fetal loss and aPL-induced IUGR. CONCLUSION:ApoER2 plays a major role in the attenuation of trophoblast function by aPL, and the receptor mediates aPL-induced pregnancy complications in vivo in mice. ApoER2-directed interventions can now potentially be developed to combat the pregnancy complications associated with APS.
Authors: S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis Journal: J Thromb Haemost Date: 2006-02 Impact factor: 5.824
Authors: Divya Seetharam; Chieko Mineo; Andrew K Gormley; Linda L Gibson; Wanpen Vongpatanasin; Ken L Chambliss; Lisa D Hahner; Melissa L Cummings; Richard L Kitchens; Yves L Marcel; Daniel J Rader; Philip W Shaul Journal: Circ Res Date: 2005-12-08 Impact factor: 17.367
Authors: N Di Simone; E Raschi; C Testoni; R Castellani; M D'Asta; T Shi; S A Krilis; A Caruso; P L Meroni Journal: Ann Rheum Dis Date: 2004-07-15 Impact factor: 19.103
Authors: Melissa J Mulla; Jan J Brosens; Larry W Chamley; Ian Giles; Charis Pericleous; Anisur Rahman; Shawna K Joyce; Britta Panda; Michael J Paidas; Vikki M Abrahams Journal: Am J Reprod Immunol Date: 2009-08 Impact factor: 3.886
Authors: Uwe Beffert; Andre Durudas; Edwin J Weeber; Peggy C Stolt; Klaus M Giehl; J David Sweatt; Robert E Hammer; Joachim Herz Journal: J Neurosci Date: 2006-02-15 Impact factor: 6.167
Authors: Guillermina Girardi; Dmitry Yarilin; Joshua M Thurman; V Michael Holers; Jane E Salmon Journal: J Exp Med Date: 2006-08-21 Impact factor: 14.307
Authors: Haiyan Chu; Anastasia Sacharidou; An Nguyen; Chun Li; Ken L Chambliss; Jane E Salmon; Yu-Min Shen; Julie Lo; Gustavo W Leone; Joachim Herz; David Y Hui; Denise K Marciano; Vikki M Abrahams; Bryony V Natale; Alina P Montalbano; Xue Xiao; Lin Xu; David R Natale; Philip W Shaul; Chieko Mineo Journal: Circ Res Date: 2021-08-18 Impact factor: 23.213
Authors: Stefan M Gysler; Melissa J Mulla; Marta Guerra; Jan J Brosens; Jane E Salmon; Lawrence W Chamley; Vikki M Abrahams Journal: Mol Hum Reprod Date: 2016-03-29 Impact factor: 4.025
Authors: Anastasia Sacharidou; Ken L Chambliss; Victoria Ulrich; Jane E Salmon; Yu-Min Shen; Joachim Herz; David Y Hui; Lance S Terada; Philip W Shaul; Chieko Mineo Journal: Blood Date: 2018-03-02 Impact factor: 25.476
Authors: Nadine Müller-Calleja; Anne Hollerbach; Jennifer Royce; Svenja Ritter; Denise Pedrosa; Thati Madhusudhan; Sina Teifel; Myriam Meineck; Friederike Häuser; Antje Canisius; T Son Nguyen; Johannes Braun; Kai Bruns; Anna Etzold; Ulrich Zechner; Susanne Strand; Markus Radsak; Dennis Strand; Jian-Ming Gu; Julia Weinmann-Menke; Charles T Esmon; Luc Teyton; Karl J Lackner; Wolfram Ruf Journal: Science Date: 2021-03-12 Impact factor: 63.714